Cardiac Mapping Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Cardiac Mapping Market Report is Segmented by Type (Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, and Other Indications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Cardiac Mapping Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cardiac Mapping Market Size

Cardiac Mapping Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 2.17 Billion
Market Size (2030) USD 3.34 Billion
CAGR (2025 - 2030) 8.99 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Cardiac Mapping Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Cardiac Mapping Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cardiac Mapping Market Analysis

The Cardiac Mapping Market size is estimated at USD 2.17 billion in 2025, and is expected to reach USD 3.34 billion by 2030, at a CAGR of 8.99% during the forecast period (2025-2030).

Factors such as a rise in cardiac diseases and manufacturers' novel technological innovations in cardiac mapping devices are expected to drive market growth over the forecast period. As more individuals are diagnosed with coronary artery disease, there is a greater demand for precise diagnostic tools and technologies to assess the condition of the heart. For instance, as per the October 2022 update from the Center for Disease Control and Prevention (CDC), about 20.1 million adults aged 20 and older were diagnosed with coronary artery disease (about 7.2%) in the United States. Hence, with the high number of cardiac complications, the demand for cardiac mapping is expected to increase, boosting market growth over the forecast period.

Similarly, as per the BHF Global CVD Factsheet 2022, around 550 million people worldwide had heart and circulatory diseases in 2022. Thus, cardiac mapping plays a vital role in this process by providing detailed information about the heart's electrical activity and identifying abnormal rhythms or areas of concern. This is expected to further increase the demand for cardiac mapping, boosting market growth over the forecast period.

Product launches, strategic acquisitions, and partnerships by key players are further expected to increase product availability and competition in the market. For instance, in January 2022, Medtronic PLC entered a definitive agreement to acquire Affera Inc. at USD 925 million. Affera designs and manufactures cardiac mapping, navigation systems, and catheter-based cardiac ablation technologies. Similarly, in September 2022, Johnson & Johnson MedTech's subsidiary, Biosense Webster, unveiled its latest innovation, the Octaray mapping catheter. Thus, due to the rise in product approvals, launches, and technological advancements in cardiac mapping, the market studied is expected to grow significantly over the forecast period.

Therefore, factors such as the growing incidence of cardiac complications and manufacturers focusing on acquisition, approvals, and technological advancements for cardiac mapping are expected to fuel the market's growth during the forecast period. However, the lack of skilled electrophysiologists is likely to hinder the market's growth.

Cardiac Mapping Industry Overview

The market is fragmented and consists of several major players. Key players are focused on strategic initiatives such as mergers, acquisitions, partnerships, and product launches to increase their global market presence. Biosense Webster Inc., Abbott, Medtronic, Boston Scientific Corporation, and Acutus Medical are some of the key players in the cardiac mapping market.

Cardiac Mapping Market Leaders

  1. Medtronic Plc

  2. Boston Scientific Corporation

  3. Acutus Medical

  4. Johnson & Johnson

  5. Abbott

  6. *Disclaimer: Major Players sorted in no particular order
Cardiac Mapping Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cardiac Mapping Market News

  • May 2024: Biosense Webster Inc., a division of Johnson & Johnson MedTech, unveiled the CARTO 3 System Version 8. This upgraded iteration of the esteemed three-dimensional (3D) heart mapping system is designed for use in cardiac ablation procedures.
  • July 2023: Biosense Webster Inc. launched the OPTRELL Mapping Catheter with TRUEref Technology in the United States, leveraging the CARTO 3 System.

Cardiac Mapping Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumption and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Cardiovascular Complications
    • 4.2.2 Rise in Technological Advancements in Cardiac Mapping Systems
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled and Experienced Electrophysiologists
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Type
    • 5.1.1 Contact Cardiac Mapping Systems
    • 5.1.2 Non-contact Cardiac Mapping Systems
  • 5.2 By Indication
    • 5.2.1 Atrial Fibrillation
    • 5.2.2 Atrial Flutter
    • 5.2.3 Other Indications
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Acutus Medical
    • 6.1.3 Angiodynamics
    • 6.1.4 APN Health LLC
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Biosig Technologies Inc.
    • 6.1.7 Boston Scientific Corporation
    • 6.1.8 Kardium Inc.
    • 6.1.9 Koninklijke Philips NV
    • 6.1.10 Lepu Medical
    • 6.1.11 Medtronic PLC
    • 6.1.12 Microport Scientific Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cardiac Mapping Industry Segmentation

As per the scope, cardiac mapping is an electrophysiology study that aims to understand the cause of heart rhythm problems like arrhythmia. Mapping the heart's electrical activity is critical for diagnosing and treating heart disease.

The cardiac mapping market is segmented by type, indication, and geography. By type, the market is segmented into contact cardiac mapping systems and non-contact cardiac mapping systems. By indication, the market is segmented into atrial fibrillation, atrial flutter, and other indications. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD) for the above segments.

By Type Contact Cardiac Mapping Systems
Non-contact Cardiac Mapping Systems
By Indication Atrial Fibrillation
Atrial Flutter
Other Indications
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cardiac Mapping Market Research FAQs

How big is the Cardiac Mapping Market?

The Cardiac Mapping Market size is expected to reach USD 2.17 billion in 2025 and grow at a CAGR of 8.99% to reach USD 3.34 billion by 2030.

What is the current Cardiac Mapping Market size?

In 2025, the Cardiac Mapping Market size is expected to reach USD 2.17 billion.

Who are the key players in Cardiac Mapping Market?

Medtronic Plc, Boston Scientific Corporation, Acutus Medical, Johnson & Johnson and Abbott are the major companies operating in the Cardiac Mapping Market.

Which is the fastest growing region in Cardiac Mapping Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Cardiac Mapping Market?

In 2025, the North America accounts for the largest market share in Cardiac Mapping Market.

What years does this Cardiac Mapping Market cover, and what was the market size in 2024?

In 2024, the Cardiac Mapping Market size was estimated at USD 1.97 billion. The report covers the Cardiac Mapping Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Cardiac Mapping Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cardiac Mapping Industry Report

Statistics for the 2025 Cardiac Mapping market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cardiac Mapping analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.